The EBMT

The EBMT Connecting the scientific community and patient care to advance cellular therapies and hematopoietic cell transplantation.

Since 1974, we drive research, collaboration and innovation to improve patients' lives worldwide. We host a unique patient registry providing a pool of data to perform studies and assess new trends. Our community of healthcare professionals is focused on innovation, research and the advancement of these fields to save and improve the lives of patients with blood-related disorders. Visit www.ebmt.o

rg to learn more about membership, JACIE Accreditation, educational opportunities and how to get involved.

Good news, the on-demand access to watch   has been extended - enjoy the meeting content for two more weeks until ⏰ Sund...
24/04/2026

Good news, the on-demand access to watch has been extended - enjoy the meeting content for two more weeks until ⏰ Sunday 10 May at 23:59 CEST. 💻

✍️ Revisit your favourite sessions and other congress highlights to learn the latest advances in the field. The on-demand access can also be purchased in case you missed it: https://www.ebmt.org/annual-meeting/on-demand

16/04/2026

🎧 New podcast is out! Hosts Michelle and Hilda take a deep dive into GvHD, one of the most common, complex, and emotionally challenging complications following HCT.

They’re joined by Elizabeth Orrin, a consultant dermatologist specialising in transplant dermatology, who shares expert insights, practical advice, and a truly patient-centred perspective on managing both acute and chronic skin GvHD.

🎧 Watch on YouTube or listen on Spotify!

08/04/2026

🚀 From microscope to machine learning: Scaling CAR-T monitoring with AI

At EBMT 2026, Dr Roni Shouval (Memorial Sloan Kettering Cancer Center) shared how his team is turning routine blood smears into a high-throughput, AI-powered platform for tracking immune responses after CAR-T therapy.

This approach could make immune monitoring faster, more scalable, and more personalised - giving clinicians better insight into patient outcomes over time.

Read the Q&A: https://touchhaematology.com/insight/scaling-car-t-monitoring-with-ai/

The EBMT
-T

08/04/2026

💡 What makes a Future Leader?

Nominations for touchHEMATOLOGY Future Leaders 2026 are now open, and we’re looking for individuals who demonstrate:

🔹Significant contributions to research and innovation
🔹Excellence in patient care and collaboration
🔹Active participation in meetings and conferences
🔹Engagement in societies and young leadership groups

Do you know someone shaping the future of the field?

👉 Nominate them today: https://touchhaematology.com/insight/nominate-a-rising-star-for-touchhaematology-future-leaders-2026/

08/04/2026

How do you measure the life of a person? In minutes, hours, days? Or in the countless lives they have touched and saved?

Today marks 100 years since the birth of Jon van Rood, our founder, and the scientist whose discovery of HLA transformed the future of medicine.

Jon’s life unfolded during a century of extraordinary scientific progress: the discovery of Penicillin, the development of vaccines, and the identification of DNA. Yet among these milestones, his work stands out. By uncovering the human leukocyte antigen (HLA) system, Jon reshaped transplantation and revolutionised the treatment of blood cancers and disorders.

In the 1950s, whilst Jon was working at Leiden University Medical Center, children diagnosed with Leukaemia often survived only months. Today, in high-income countries, survival rates for children can reach 90%. That transformation is part of Jon’s legacy.

Though Jon was never one to consider the work finished. A pioneer with a global vision, he understood that scientific breakthroughs alone were not enough. At the time, unrelated donor transplantation was becoming a clinical reality though major challenges remained. Finding a suitable match was, and still is, one of the most critical. National registries emerged, yet each lacked the diversity needed to serve all patients. Jon’s solution was visionary: a global network. Therefore, he created Bone Marrow Donors Worldwide (BMDW), a bold step toward connecting patients and donors across borders.

Today, 57 countries use the evolved BMDW (now known as WMDA's Search & Match Service), an enduring testament to his idea that collaboration saves lives. And his legacy continues to guide the World Marrow Donor Association in expanding access, so that every patient, everywhere, has a chance at a cure.

It has been nearly nine years since Jon passed away. Yet his presence is felt every day. We often reflect on what he might think of the world he helped shape: more than 44 million voluntary stem cell donors worldwide, and over 28,000 patients each year given a second chance at life through global donor matching.

And that is only part of his legacy. Jon also founded Stichting Matchis, Eurotransplant, and The EBMT. Institutions that continue to save and improve lives every day.

This morning, we shared memories of Jon, stories of his vision, his determination, and the profound impact he had on each of us. So many of us owe him more than we can ever fully express. We invite you to remember Jon today and share your memories of him or how he has touched your life.

Happy 100th birthday, Jon.

Missed your chance to attend the 52nd Annual Meeting of the EBMT? 🧑‍⚕️   🔓 Unlock the Annual Meeting's best content from...
02/04/2026

Missed your chance to attend the 52nd Annual Meeting of the EBMT? 🧑‍⚕️

🔓 Unlock the Annual Meeting's best content from anywhere in the world with virtual on-demand access to watch the recordings via the Virtual Meeting Platform or the EBMT 2026 App.

💻 Purchase access to watch the on-demand recordings until 25 April 2026 at 23:59 CEST ⬇️
https://www.ebmt.org/annual-meeting/on-demand

🖱️ Discounts available for EBMT Members, LMIC Residents and Quality Management Day Pass.

✅ Plus, earn up to 26 EBAH-CME credit points by watching the on-demand content.

Please note that some sessions and presentations are pending review and that some speakers may not consent to the publication of their content on-demand.

01/04/2026
01/04/2026

📢 Don’t forget to nominate your touchHAEMATOLOGY Future Leaders 2026!

Last year, we recognized Dr Carmelo Gurnari as a Future Leader 2025 for his achievements in the field of head and neck cancer:

“I am delighted to have been nominated in 2025 by touchHAEMATOLOGY as a Future Leader in the field! By bridging the gap between basic science and clinical practice, empowering junior members and strengthening international collaborations, my goal in haematology is to translate the new evidence of molecular biology into practice-changing innovations.”

Is there a rising star you think should be on our 2026 list?

✨ Make your nomination today: https://touchhaematology.com/insight/nominate-a-rising-star-for-touchhaematology-future-leaders-2026/

📄Revisit our 2025 list: https://touchhaematology.com/insight/touchhaematology-future-leaders-2025/

Dirección

Aticco Med Fórum, Passeig De Garcia Fària, 49
Barcelona
08010

Página web

http://www.ebmt.org/

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando The EBMT publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.

Compartir